2026 HealthSpring Assurance Rx (PDP) formulary (drug list)
Contract S5617, plan 221 · Michigan · 3,188 drugs on file · formulary ID 00026089. Each drug links to its cost in every CMS PDP Region 13 plan.
155 drugs starting with S.
| Drug name | Tier | 30-day preferred pharmacy | 90-day mail order | Usage management |
|---|---|---|---|---|
| SACUBITRIL AND VALSARTAN 24/26 mg Tablet, Film Coated | 3Preferred Brand | 25% | 25% |
|
| SACUBITRIL AND VALSARTAN 49/51 mg Tablet, Film Coated | 3Preferred Brand | 25% | 25% |
|
| SACUBITRIL AND VALSARTAN 97/103 mg Tablet, Film Coated | 3Preferred Brand | 25% | 25% |
|
| SAJAZIR 30 mg/3mL InjectionIcatibant | 5Specialty Tier | 25% | N/A |
|
| SANCUSO 3.1 mg/24h PatchGranisetron | 5Specialty Tier | 25% | N/A | None |
| SAPROPTERIN DIHYDROCHLORIDE 100 mg Powder, For Solution | 5Specialty Tier | 25% | N/A |
|
| SAPROPTERIN DIHYDROCHLORIDE 100 mg Tablet | 5Specialty Tier | 25% | N/A |
|
| SAPROPTERIN DIHYDROCHLORIDE 500 mg Powder, For Solution | 5Specialty Tier | 25% | N/A |
|
| SCEMBLIX 100 mg Tablet, Film CoatedAsciminib | 5Specialty Tier | 25% | N/A |
|
| SCEMBLIX 20 mg Tablet, Film CoatedAsciminib | 5Specialty Tier | 25% | N/A |
|
| SCEMBLIX 40 mg Tablet, Film CoatedAsciminib | 5Specialty Tier | 25% | N/A |
|
| SCOPOLAMINE 1 mg/3d Patch | 4Non-Preferred Drug | 30% | 30% |
|
| SECUADO 3.8 mg/d Film, Extended ReleaseAsenapine | 5Specialty Tier | 25% | N/A |
|
| SECUADO 5.7 mg/d Film, Extended ReleaseAsenapine | 5Specialty Tier | 25% | N/A |
|
| SECUADO 7.6 mg/d Film, Extended ReleaseAsenapine | 5Specialty Tier | 25% | N/A |
|
| SELARSDI 45 mg/.5mL Injection, SolutionUstekinumab-Aekn | 3Preferred Brand | 25% | 25% |
|
| SELARSDI 45 mg/.5mL Injection, SolutionUstekinumab-Aekn | 3Preferred Brand | 25% | 25% |
|
| SELARSDI 90 mg/mL Injection, SolutionUstekinumab-Aekn | 5Specialty Tier | 25% | N/A |
|
| SELEGILINE HYDROCHLORIDE 5 mg Capsule | 3Preferred Brand | 25% | 25% | None |
| SELEGILINE HYDROCHLORIDE 5 mg Tablet | 3Preferred Brand | 25% | 25% | None |
| SELENIUM SULFIDE 2.5 mg/100mL Lotion | 2Generic | 10% | 10% | None |
| SELZENTRY KitMaraviroc | 5Specialty Tier | 25% | N/A | None |
| SEREVENT DISKUS 50 ug Powder, MeteredSalmeterol Xinafoate | 3Preferred Brand | 25% | 25% |
|
| SERTRALINE HYDROCHLORIDE 100 mg Tablet, Film Coated | 1Preferred Generic | 5% | 5% |
|
| SERTRALINE HYDROCHLORIDE 20 mg/mL Solution, Concentrate | 4Non-Preferred Drug | 30% | 30% | None |
| SERTRALINE HYDROCHLORIDE 25 mg Tablet, Film Coated | 1Preferred Generic | 5% | 5% |
|
| SERTRALINE HYDROCHLORIDE 50 mg Tablet, Film Coated | 1Preferred Generic | 5% | 5% |
|
| SETLAKIN KitLevonorgestrel And Ethinyl Estradiol | 4Non-Preferred Drug | 30% | 30% | None |
| SEVELAMER CARBONATE 800 mg Tablet, Film Coated | 4Non-Preferred Drug | 30% | 30% |
|
| SEVELAMER CARBONATE 800 mg/930mg For Suspension | 4Non-Preferred Drug | 30% | 30% |
|
| SEVELAMER CARBONATE FOR ORAL SUSPENSION 2400 mg Powder, For Suspension | 4Non-Preferred Drug | 30% | 30% |
|
| SHAROBEL KitNorethindrone | 4Non-Preferred Drug | 30% | 30% | None |
| SHINGRIX 50 ug/.5mL Injection, SolutionZoster Vaccine Recombinant, Adjuvanted | 3Preferred Brand | 25% | 25% |
|
| SHINGRIX KitZoster Vaccine Recombinant, Adjuvanted | 3Preferred Brand | 25% | 25% |
|
| SIGNIFOR .3 mg/mL InjectionPasireotide | 5Specialty Tier | 25% | N/A |
|
| SIGNIFOR .6 mg/mL InjectionPasireotide | 5Specialty Tier | 25% | N/A |
|
| SIGNIFOR .9 mg/mL InjectionPasireotide | 5Specialty Tier | 25% | N/A |
|
| SILDENAFIL 20 mg Tablet | 3Preferred Brand | 25% | 25% |
|
| SILVER SULFADIAZINE 10 mg/g Cream | 3Preferred Brand | 25% | 25% | None |
| SIMVASTATIN 10 mg Tablet, Film Coated | 1Preferred Generic | 5% | 5% |
|
| SIMVASTATIN 20 mg Tablet, Film Coated | 1Preferred Generic | 5% | 5% |
|
| SIMVASTATIN 40 mg Tablet, Film Coated | 1Preferred Generic | 5% | 5% |
|
| SIMVASTATIN 5 mg Tablet, Film Coated | 1Preferred Generic | 5% | 5% |
|
| SIMVASTATIN 80 mg Tablet, Film Coated | 1Preferred Generic | 5% | 5% |
|
| SIROLIMUS .5 mg Tablet, Film Coated | 4Non-Preferred Drug | 30% | 30% |
|
| SIROLIMUS 1 mg Tablet | 4Non-Preferred Drug | 30% | 30% |
|
| SIROLIMUS 1 mg/mL Solution | 4Non-Preferred Drug | 30% | 30% |
|
| SIROLIMUS 2 mg Tablet | 4Non-Preferred Drug | 30% | 30% |
|
| SIRTURO 100 mg TabletBedaquiline Fumarate | 5Specialty Tier | 25% | N/A |
|
| SIRTURO 20 mg TabletBedaquiline Fumarate | 4Non-Preferred Drug | 30% | 30% |
|
| SIVEXTRO 200 mg Tablet, Film CoatedTedizolid Phosphate | 5Specialty Tier | 25% | N/A |
|
| SIVEXTRO 200 mg/4mL Injection, Powder, Lyophilized, For SolutionTedizolid Phosphate | 5Specialty Tier | 25% | N/A |
|
| SKYRIZI 150 mg/mL InjectionRisankizumab-Rzaa | 5Specialty Tier | 25% | N/A |
|
| SKYRIZI 150 mg/mL InjectionRisankizumab-Rzaa | 5Specialty Tier | 25% | N/A |
|
| SKYRIZI KitRisankizumab-Rzaa | 5Specialty Tier | 25% | N/A |
|
| SKYRIZI KitRisankizumab-Rzaa | 5Specialty Tier | 25% | N/A |
|
| SODIUM CHLORIDE 3 g/100mL Injection, Solution | 4Non-Preferred Drug | 30% | 30% | None |
| SODIUM CHLORIDE 4.5 g/1000mL Injection, Solution | 4Non-Preferred Drug | 30% | 30% | None |
| SODIUM CHLORIDE 5 g/100mL Injection, Solution | 4Non-Preferred Drug | 30% | 30% | None |
| SODIUM CHLORIDE 9 g/1000mL Injection, Solution | 4Non-Preferred Drug | 30% | 30% | None |
| SODIUM CHLORIDE 900 mg/100mL Irrigant | 4Non-Preferred Drug | 30% | 30% | None |
| SODIUM OXYBATE .5 g/mL Solution | 5Specialty Tier | 25% | N/A |
|
| SODIUM PHENYLBUTYRATE .94 g/g Powder | 5Specialty Tier | 25% | N/A |
|
| SODIUM PHENYLBUTYRATE 500 mg TabletSodium Phenylbutyrate Tablets, 500 Mg | 5Specialty Tier | 25% | N/A |
|
| SODIUM POLYSTYRENE SULFONATE 1 g/g Powder | 3Preferred Brand | 25% | 25% | None |
| SODIUM POLYSTYRENE SULFONATE 15 g/60mL Suspension | 3Preferred Brand | 25% | 25% | None |
| SODIUM SULFATE, POTASSIUM SULFATE, AND MAGNESIUM SULFATE BOWEL PREP KIT 17.5/3.13/1.6 g/177mL SolutionSodium Sulfate Anhydrous, Potassium Sulfate, And Magnesium Sulfate | 3Preferred Brand | 25% | 25% | None |
| SOLIFENACIN SUCCINATE 10 mg Tablet, Film Coated | 4Non-Preferred Drug | 30% | 30% | None |
| SOLIFENACIN SUCCINATE 5 mg Tablet, Film Coated | 4Non-Preferred Drug | 30% | 30% | None |
| SOLIQUA 100/33 100/33 U/mL/ug/mL Injection, SolutionInsulin Glargine And Lixisenatide | 3Preferred Brand | 25% | 25% |
|
| SOLTAMOX 20 mg/10mL LiquidTamoxifen Citrate | 5Specialty Tier | 25% | N/A | None |
| SOMAVERT KitPegvisomant | 5Specialty Tier | 25% | N/A |
|
| SOMAVERT KitPegvisomant | 5Specialty Tier | 25% | N/A |
|
| SOMAVERT KitPegvisomant | 5Specialty Tier | 25% | N/A |
|
| SOMAVERT KitPegvisomant | 5Specialty Tier | 25% | N/A |
|
| SOMAVERT KitPegvisomant | 5Specialty Tier | 25% | N/A |
|
| SORAFENIB 200 mg Tablet, Film Coated | 5Specialty Tier | 25% | N/A |
|
| SOTALOL HYDROCHLORIDE 120 mg Tablet | 2Generic | 10% | 10% | None |
| SOTALOL HYDROCHLORIDE 120 mg Tablet | 2Generic | 10% | 10% | None |
| SOTALOL HYDROCHLORIDE 160 mg Tablet | 2Generic | 10% | 10% | None |
| SOTALOL HYDROCHLORIDE 240 mg Tablet | 2Generic | 10% | 10% | None |
| SOTALOL HYDROCHLORIDE 80 mg Tablet | 2Generic | 10% | 10% | None |
| SOTALOL HYDROCHLORIDE 80 mg Tablet | 2Generic | 10% | 10% | None |
| SOTALOL HYDROCHLORIDE AF 160 mg TabletSotalol Hydrochloride Tablets Af | 2Generic | 10% | 10% | None |
| SOTYLIZE 5 mg/mL SolutionSotalol Hydrochloride | 4Non-Preferred Drug | 30% | 30% | None |
| SPIRIVA RESPIMAT 1.562 ug Spray, MeteredTiotropium Bromide Inhalation Spray | 4Non-Preferred Drug | 30% | 30% |
|
| SPIRIVA RESPIMAT 3.124 ug Spray, MeteredTiotropium Bromide Inhalation Spray | 4Non-Preferred Drug | 30% | 30% |
|
| SPIRONOLACTONE 100 mg Tablet | 2Generic | 10% | 10% | None |
| SPIRONOLACTONE 25 mg Tablet | 2Generic | 10% | 10% | None |
| SPIRONOLACTONE 50 mg Tablet | 2Generic | 10% | 10% | None |
| SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE 25/25 mg Tablet | 2Generic | 10% | 10% | None |
| SPRINTEC KitNorgestimate And Ethinyl Estradiol | 3Preferred Brand | 25% | 25% | None |
| SPRITAM 250 mg Tablet, For SuspensionLevetiracetam | 4Non-Preferred Drug | 30% | 30% | None |
| SPRITAM 500 mg Tablet, For SuspensionLevetiracetam | 4Non-Preferred Drug | 30% | 30% | None |
| SSD CREAM 10 g/1000g CreamSilver Sulfadiazine | 3Preferred Brand | 25% | 25% | None |
| STELARA 45 mg/.5mL Injection, SolutionUstekinumab | 5Specialty Tier | 25% | N/A |
|
| STELARA 45 mg/.5mL Injection, SolutionUstekinumab | 5Specialty Tier | 25% | N/A |
|
| STELARA 90 mg/mL Injection, SolutionUstekinumab | 5Specialty Tier | 25% | N/A |
|
| STIVARGA 40 mg Tablet, Film CoatedRegorafenib | 5Specialty Tier | 25% | N/A |
|
| STREPTOMYCIN 1 g Injection, Powder, Lyophilized, For Solution | 5Specialty Tier | 25% | N/A |
|
| STRIBILD 150/150/200/300 mg Tablet, Film CoatedElvitegravir, Cobicistat, Emtricitabine, And Tenofovir Disoproxil Fumarate | 5Specialty Tier | 25% | N/A |
|
| SUBVENITE 10 mg/mL SuspensionLamotrigine | 5Specialty Tier | 25% | N/A | None |
| SUBVENITE 100 mg TabletLamotrigine | 2Generic | 10% | 10% | None |
| SUBVENITE 150 mg TabletLamotrigine | 2Generic | 10% | 10% | None |
| SUBVENITE 200 mg TabletLamotrigine | 2Generic | 10% | 10% | None |
| SUBVENITE 25 mg TabletLamotrigine | 2Generic | 10% | 10% | None |
| SUBVENITE KitLamotrigine | 2Generic | 10% | 10% | None |
| SUBVENITE KitLamotrigine | 2Generic | 10% | 10% | None |
| SUBVENITE KitLamotrigine | 2Generic | 10% | 10% | None |
| SUCRAID 8500 [iU]/mL SolutionSacrosidase | 5Specialty Tier | 25% | N/A |
|
| SUFLAVE KitPolyethylene Glycol 3350, Sodium Sulfate, Potassium Chloride, Magnesium Sulfate, And Sodium Chloride For Oral Solution | 4Non-Preferred Drug | 30% | 30% | None |
| SULFACETAMIDE SODIUM 100 mg/mL Lotion | 4Non-Preferred Drug | 30% | 30% | None |
| SULFACETAMIDE SODIUM 100 mg/mL Solution/ Drops | 3Preferred Brand | 25% | 25% | None |
| SULFACETAMIDE SODIUM AND PREDNISOLONE SODIUM PHOSPHATE 100/2.3 mg/mL Solution/ Drops | 2Generic | 10% | 10% | None |
| SULFADIAZINE 500 mg Tablet | 4Non-Preferred Drug | 30% | 30% | None |
| SULFAMETHOXAZOLE AND TRIMETHOPRIM 200/40 mg/5mL Suspension | 4Non-Preferred Drug | 30% | 30% | None |
| SULFAMETHOXAZOLE AND TRIMETHOPRIM 400/80 mg Tablet | 2Generic | 10% | 10% | None |
| SULFAMETHOXAZOLE AND TRIMETHOPRIM 800/160 mg Tablet | 2Generic | 10% | 10% | None |
| SULFASALAZINE 500 mg Tablet | 2Generic | 10% | 10% | None |
| SULFASALAZINE 500 mg Tablet, Delayed Release | 2Generic | 10% | 10% | None |
| SULINDAC 150 mg Tablet | 2Generic | 10% | 10% | None |
| SULINDAC 200 mg Tablet | 2Generic | 10% | 10% | None |
| SUMATRIPTAN 100 mg TabletSumatriptan Succinate | 2Generic | 10% | 10% |
|
| SUMATRIPTAN 20 mg Spray | 4Non-Preferred Drug | 30% | 30% |
|
| SUMATRIPTAN 25 mg TabletSumatriptan Succinate | 2Generic | 10% | 10% |
|
| SUMATRIPTAN 5 mg Spray | 4Non-Preferred Drug | 30% | 30% |
|
| SUMATRIPTAN 50 mg TabletSumatriptan Succinate | 2Generic | 10% | 10% |
|
| SUMATRIPTAN 6 mg/.5mL Injection, Solution | 4Non-Preferred Drug | 30% | 30% |
|
| SUMATRIPTAN SUCCINATE 6 mg/.5mL Injection | 4Non-Preferred Drug | 30% | 30% |
|
| SUNITINIB MALATE 12.5 mg Capsule | 5Specialty Tier | 25% | N/A |
|
| SUNITINIB MALATE 25 mg Capsule | 5Specialty Tier | 25% | N/A |
|
| SUNITINIB MALATE 37.5 mg Capsule | 5Specialty Tier | 25% | N/A |
|
| SUNITINIB MALATE 50 mg Capsule | 5Specialty Tier | 25% | N/A |
|
| SUNLENCA 300 mg Tablet, Film CoatedLenacapavir Sodium | 5Specialty Tier | 25% | N/A | None |
| SUNLENCA 300 mg Tablet, Film CoatedLenacapavir Sodium | 5Specialty Tier | 25% | N/A | None |
| SUNLENCA 300 mg Tablet, Film CoatedLenacapavir Sodium | 5Specialty Tier | 25% | N/A | None |
| SUTAB 17.75/2.7/2.25 g TabletSodium Sulfate, Magnesium Sulfate, And Potassium Chloride | 4Non-Preferred Drug | 30% | 30% | None |
| SYEDA KitDrospirenone And Ethinyl Estradiol | 4Non-Preferred Drug | 30% | 30% | None |
| SYMPAZAN 10 mg FilmClobazam | 5Specialty Tier | 25% | N/A |
|
| SYMPAZAN 20 mg FilmClobazam | 5Specialty Tier | 25% | N/A |
|
| SYMPAZAN 5 mg FilmClobazam | 5Specialty Tier | 25% | N/A |
|
| SYMTUZA 800/150/200/10 mg Tablet, Film CoatedDarunavir, Cobicistat, Emtricitabine, And Tenofovir Alafenamide | 5Specialty Tier | 25% | N/A | None |
| SYNAREL 2 mg/mL Spray, MeteredNafarelin Acetate | 5Specialty Tier | 25% | N/A | None |
| SYNTHROID 100 ug TabletLevothyroxine Sodium | 4Non-Preferred Drug | 30% | 30% | None |
| SYNTHROID 112 ug TabletLevothyroxine Sodium | 4Non-Preferred Drug | 30% | 30% | None |
| SYNTHROID 125 ug TabletLevothyroxine Sodium | 4Non-Preferred Drug | 30% | 30% | None |
| SYNTHROID 137 ug TabletLevothyroxine Sodium | 4Non-Preferred Drug | 30% | 30% | None |
| SYNTHROID 150 ug TabletLevothyroxine Sodium | 4Non-Preferred Drug | 30% | 30% | None |
| SYNTHROID 175 ug TabletLevothyroxine Sodium | 4Non-Preferred Drug | 30% | 30% | None |
| SYNTHROID 200 ug TabletLevothyroxine Sodium | 4Non-Preferred Drug | 30% | 30% | None |
| SYNTHROID 25 ug TabletLevothyroxine Sodium | 4Non-Preferred Drug | 30% | 30% | None |
| SYNTHROID 300 ug TabletLevothyroxine Sodium | 4Non-Preferred Drug | 30% | 30% | None |
| SYNTHROID 50 ug TabletLevothyroxine Sodium | 4Non-Preferred Drug | 30% | 30% | None |
| SYNTHROID 75 ug TabletLevothyroxine Sodium | 4Non-Preferred Drug | 30% | 30% | None |
| SYNTHROID 88 ug TabletLevothyroxine Sodium | 4Non-Preferred Drug | 30% | 30% | None |
PA = prior authorization, ST = step therapy, QL = quantity limit. Costs are the plan’s initial-coverage cost-sharing from the CMS 2026 formulary files; a drug not listed here is not on this plan’s formulary, though a formulary exception may still be possible.